Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Potent cytotoxic agent against human hepatocellular carcinoma cell line based on 2-aryl hydrazonopropanal pharmacophore

Potent cytotoxic agent against human hepatocellular carcinoma cell line based on 2-aryl hydrazonopropanal pharmacophore

US Patent 10280134 · Granted May 7, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic inhibition affinity of copper (II) complex and their diazenyl pyridi2023
Tetrahydroquinoline derivatives and a process of preparation thereof2022
Pyridine derivatives for the treatment of hyperproliferative diseases2022
Pyridine derivatives for the treatment of hyperproliferative diseases2022
Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitum2021
Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitum2021
Highly efficient nanosized mesoporous CuMgAl ternary oxide catalyst2021
Method of performing coupling reactions2021
Di(2-aryl hydrozonopropanal) arene derivatives2021
Di(2-aryl hydrozonopropanal) arene derivatives2021
Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitum2021
Antimicrobial and cytotoxic compounds and methods for treating cancer, a bacteri2019